<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1205222017
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SINEMET 25-250MG TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LEVODOPA,CARBIDOPA
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250,25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        44.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Algorithm SAL" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Algorithm SAL
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Algorithm SAL
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N04BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Sinemet<sup>&reg;</sup> is indicated for the treatment of Parkinson&rsquo;s disease.&nbsp;</p><p>Sinemet<sup>&reg; </sup>improves the symptoms of Parkinson&rsquo;s disease. Parkinson&rsquo;s disease is a long-term illness where:</p><p>&bull; you become slow and unsteady.</p><p>&bull; your muscles feel stiff.</p><p>&bull; you may develop shaking or trembling (called &lsquo;tremor&rsquo;).</p><p>If not treated, Parkinson&rsquo;s disease can make it hard for you to continue your normal daily activities.</p><p>&nbsp;</p><p>Sinemet<sup>&reg;</sup> contains two different medicines called:&nbsp;</p><p>levodopa and carbidopa.</p><p>&bull; Levodopa, an aromatic amino acid, turns into a substance called &lsquo;dopamine&rsquo; in your brain. Dopamine helps improve the signs of your Parkinson&rsquo;s disease;</p><p>&bull; Carbidopa belongs to a group of medicines called&nbsp;</p><p>&lsquo;aromatic amino acid decarboxylase inhibitors&rsquo;. It helps&nbsp;</p><p>levodopa work more effectively by slowing the speed at which levodopa is broken down in your body.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Sinemet<sup>&reg;</sup>:</strong></p><p>&bull; if you are allergic to levodopa or&nbsp;</p><p>carbidopa or any of the other ingredients of this medicine (listed in Section 6)</p><p>&bull; if you have ever had skin cancer or you have any unusual moles which have not been examined by your doctor</p><p>&bull; if you are taking certain medicines called MAOIs (Monoamine Oxidase Inhibitors) used for depression. You need to stop using these medicines at least two weeks before you start Sinemet<sup>&reg;</sup> (see also under&nbsp;<strong> &ldquo;Other Medicines and Sinemet&rdquo;</strong> below)</p><p>&bull; if you have a condition called &lsquo;narrow-angle glaucoma&rsquo; that may cause a sudden build up of pressure in the eye</p><p>&bull; if you have a severe mental disorder</p><p>&bull; if you are pregnant, might become pregnant, or are&nbsp;</p><p>breastfeeding</p><p>Do not take Sinemet<sup>&reg;</sup> if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Sinemet<sup>&reg;</sup>.</p><p>&nbsp;</p><p><strong>Warnings and Precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before you take Sinemet: &nbsp;</p><p>&bull; if you have a history of fits (convulsions)</p><p>&bull; if you have had an ulcer in your gut (called &lsquo;duodenal&rsquo; or &lsquo;peptic ulcer&rsquo;) or have vomited blood</p><p>&bull; if you have had a heart attack, heart beat problems,&nbsp;</p><p>circulation or breathing problems.</p><p>&bull; if you have had kidney, liver or hormonal problems</p><p>&bull; if you have had depression or other mental problems</p><p>&bull; if you have a condition called &lsquo;chronic wide-angle&nbsp;</p><p>glaucoma&rsquo; that may cause a build-up of pressure in the eye. You will need to have regular check-ups on the pressure in your eye</p><p>&bull; if you sometimes have sudden sleep attacks or sometimes feel very sleepy</p><p>&bull; if you are due to have surgery.</p><p>&nbsp;</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Sinemet<sup>&reg;</sup>.</p><p>&nbsp;</p><p>Tell your doctor if you or your family/carer notices you are developing addiction-like symptoms leading to craving for large doses of Sinemet and other medicines used to treat Parkinson&rsquo;s disease.</p><p>&nbsp;</p><p>Tell your doctor if you or your family/carer notices you are developing urges or cravings to behave in ways that are unusual for you or you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These behaviors are called impulse control disorders and can include addictive gambling, excessive eating or spending, an abnormally high sex drive or an increase in sexual thoughts or feelings. Your doctor may need to review your treatments.</p><p>&nbsp;</p><p><strong>Other Medicines and Sinemet</strong></p><p>Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription. This includes herbal medicines. This is because Sinemet<sup>&reg;</sup> can affect the way some other medicines work. Also some other medicines can affect the way Sinemet<sup>&reg;</sup> works.</p><p>&nbsp;</p><p>In particular tell your doctor or pharmacist if you are taking any of the following medicines:</p><p>&bull; Medicines for Parkinson&rsquo;s disease containing levodopa:&nbsp;</p><p>&nbsp; - If they are &lsquo;slow release&rsquo;, you will need to wait 24 hours after your last dose before starting Sinemet.</p><p>&nbsp; - If they are &lsquo;normal release&rsquo;, you will need to wait 12 hours after your last dose before starting Sinemet</p><p>&nbsp; - Tell the doctor or pharmacist even if you have only taken &nbsp; them in the past.</p><p>Medicines for Parkinson&rsquo;s disease which do not contain levodopa will usually be continued. However, your dose may be changed.</p><p>&bull; Medicines for mental problems (including depression), tuberculosis (TB), high blood pressure, muscle spasms, epilepsy or other diseases related to involuntary&nbsp;</p><p>movements. Your dose may need to be changed.</p><p>&bull; Medicines to treat low iron. Your dose may need to be changed</p><p>&bull; Medicines called monoamine oxidase inhibitors (see also <strong>&lsquo;Do not take Sinemet&rsquo;</strong>).</p><p>&bull; Anticholinergic medicines (such as orphenadrine, trihexyphenidyl, benzatropine and procyclidine). Your dose may need to be changed.</p><p>&bull; Phenytoin which is used to treat fits (convulsions)&nbsp;</p><p>&bull; Papaverine which is used to treat impotence in men.</p><p>&nbsp;</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking this medicine. Your doctor or pharmacist has a more complete list of medicines to avoid while taking Sinemet<sup>&reg;</sup>.</p><p>&nbsp;</p><p><strong>Tests while you are taking Sinemet<sup>&reg;</sup></strong></p><p>This medication can affect some laboratory tests that your doctor may perform on blood or urine samples. Please remind your doctor if you are taking Sinemet and are having any tests.</p><p>&nbsp;</p><p><strong>Taking Sinemet<sup>&reg;</sup> with food and drink</strong></p><p>Try to avoid taking your tablets with a heavy meal. If your diet contains too much protein (meat, eggs, milk, cheese), Sinemet<sup>&reg;</sup> may not work as well as it should.</p><p>&nbsp;</p><p><strong>Pregnancy and breastfeeding</strong></p><p>Do not take Sinemet<sup>&reg;</sup> if you are pregnant, might become pregnant or are breastfeeding. Levodopa, one of the substances in Sinemet<sup>&reg;</sup>, is passed into human milk. Ask your doctor or pharmacist for advice before taking any medicine, if you are pregnant or breastfeeding.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>&bull;Sinemet<sup>&reg;</sup> affects different people in different ways. Some people have side effects which affect their ability to drive or use tools or machines (see Section 4 Possible side effects). Do not drive or use tools or machines if you get these effects.&nbsp;</p><p>&bull;Sinemet<sup>&reg;</sup> can also make you sleepy or cause &lsquo;sudden sleep attacks&rsquo;. If this happens to you, you must not drive or use tools or machines. Your doctor will tell you if you can start driving again if these attacks stop.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Taking this medicine</strong></p><p>&bull; If the tablet breaks when you remove it from the blister pack, make sure you have all of the tablet pieces (the full dose). If you do not have all the pieces of a broken tablet, throw away the pieces and take another tablet from the blister pack.&nbsp;</p><p>&bull; Taking only part of a tablet (a partial dose) may cause symptoms to get worse</p><p>&bull; Take this medicine by mouth.&nbsp;</p><p>&bull; Although your medicine can have an effect after one day, it may take up to seven days to work.</p><p>&bull; Take your tablets at regular time intervals according to your doctor&rsquo;s instructions.</p><p>&bull; Do not change the times at which you take your tablets or take any other medicines for Parkinson&rsquo;s disease without first consulting your doctor.</p><p>&bull; Try to avoid taking your tablets with a heavy meal.</p><p>&nbsp;</p><p><strong>If you have not had levodopa before</strong></p><p>The recommended&nbsp; dose is:</p><p>&bull; For Sinemet<sup>&reg;</sup> 25/100 mg tablets: one tablet three times a day.&nbsp;</p><p>&nbsp;</p><p><strong>If you have had levodopa before</strong></p><p>&bull; Your doctor will ask you to stop taking your medicine for Parkinson&rsquo;s disease before you start taking Sinemet<sup>&reg;</sup>.</p><p>The recommended dose is:&nbsp;</p><p>&bull; for Sinemet<sup>&reg;</sup> 25 mg/100 mg Tablets and Sinemet<sup>&reg;</sup> 25 mg/250 mg Tablets: one tablet three or four times a day.</p><p>&nbsp;</p><p>More than one Sinemet<sup>&reg;</sup> product dosage may be prescribed by your doctor. If you have been given different Sinemet<sup>&reg;</sup> tablets to take, make sure that you are taking the correct one at the right time.</p><p>&nbsp;</p><p><strong>Use in children and adolescents</strong></p><p>Sinemet<sup>&reg;</sup> is not suitable for children under the age of 18 years.</p><p>&nbsp;</p><p><strong>If you take more Sinemet<sup>&reg;</sup> than you should</strong></p><p>If you take too many tablets see your doctor immediately.</p><p>&nbsp;</p><p><strong>If you forget to take Sinemet<sup>&reg;</sup></strong></p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop taking Sinemet<sup>&reg;</sup></strong></p><p>Do not stop taking Sinemet<sup>&reg;</sup> or change your dose without talking to your doctor first. When you stop taking Sinemet<sup>&reg;</sup> the following can occur: stiff muscles, high temperature (fever) and mental changes.</p><p>&nbsp;</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Sinemet<sup>&reg;</sup> can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>Stop taking Sinemet<sup>&reg; </sup>and see your doctor straight away, if you notice any of the following side effects:</strong></p><p>- allergic reaction, the signs may include hives (nettle rash), itching, rash, swelling of your face, lips, tongue or throat. This may cause difficulty in breathing or swallowing</p><p>- chest pain</p><p>- uneven (irregular) heart beat or palpitations</p><p>- dizziness on standing-up quickly</p><p>- bleeding from your gut which may be seen as blood in your faeces or darkened faeces (gastro-intestinal bleeding)</p><p>- blood problems, the signs may include pale skin (pallor), tiredness, fever, sore throat or mild bruising and prolonged bleeding after injury</p><p>- stiff muscles, high fever</p><p>- mental changes including delusions, hallucinations and depression</p><p>- fits (convulsions).</p><p>&nbsp;</p><p><strong>The most common side effects are</strong></p><p>- abnormal movements such as twitching or spasms (which may or may not be like your Parkinson&rsquo;s symptoms)</p><p>- nausea</p><p>- urinary tract infections.</p><p>&nbsp;</p><p><strong>Other side effects include</strong></p><p>- fainting, anorexia, high blood pressure</p><p>- inflammation of the veins, being sick (vomiting) diarrhoea, discoloration of urine, sweat or saliva</p><p>- on-off phenomenon, characteristic of some people with long-standing Parkinson&rsquo;s disease. This is when you can have unpredictable changes from being mobile - &ldquo;on&rdquo; - to a sudden inability to move - &ldquo;off&rdquo;. &ldquo;Off&rdquo; to &ldquo;on&rdquo; can occur just as suddenly.</p><p>- dizziness; sleepiness (including excessive drowsiness or sudden sleep onset episodes), pins and needles</p><p>- dream abnormalities, confusion, feeling agitated, shortness of breath, hair loss</p><p>&nbsp;</p><p><strong>You may experience the following side effects:</strong></p><p>- Craving for large doses of Sinemet in excess of that required to control motor symptoms, known as dopamine dysregulation syndrome. Some patients experience severe abnormal involuntary movements (dyskinesias), mood swings or other side effects after taking large doses of Sinemet</p><p>- inability to resist the impulse to perform an action that could be harmful, which may include:</p><p>&nbsp; &bull; strong impulse to gamble excessively despite serious personal or family consequences</p><p>&nbsp; &bull; altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive</p><p>&nbsp; &bull; uncontrollable excessive shopping or spending</p><p>&nbsp; &bull; binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger).</p><p>&nbsp;</p><p><strong>Tell your doctor if you experience any of these behaviours; he/she will discuss ways of managing or reducing the symptoms.</strong></p><p>&nbsp;</p><p><strong>Side effects that have been reported with medicines containing levodopa.</strong></p><p>These may be experienced when taking Sinemet<sup>&reg;</sup>.</p><p>&nbsp;</p><p><em>Nervous system:</em></p><p>- loss of control over the voluntary movements of everyday life</p><p>- numbness, increased hand tremor, muscle twitching, muscle cramp, irregular movement of jaw muscles resulting in difficulty opening the mouth</p><p>- difficulty sleeping, feeling anxious or high, falling over and abnormal walking patterns</p><p>- headache</p><p>&nbsp;</p><p><em>Eyes:</em></p><p>- drooping eyelid and dilated pupil</p><p>- changes in vision, irregular movement of the eye</p><p>&nbsp;</p><p><em>Digestive system:</em></p><p>- indigestion, dry mouth, bitter taste</p><p>- swelling of the salivary glands, difficulty swallowing, grinding of the teeth</p><p>- hiccups, abdominal pain and distress, constipation, wind</p><p>- burning sensation of the tongue.</p><p>&nbsp;</p><p><em>Sexual:</em></p><p>- persistent abnormal erection of the penis</p><p>&nbsp;</p><p><em>Urinary:</em></p><p>- difficulty passing urine or incontinence (inability to control urine flow)</p><p>&nbsp;</p><p><em>Skin:</em></p><p>- changed patches of pigmented skin, including, irritated or irregular moles, or moles in which you have noticed changes (melanoma)</p><p>&nbsp;</p><p><em>General:</em></p><p>- weight gain or loss, swelling in the limbs</p><p>- flushing, hot flushes, increased sweating</p><p>- feeling weak, faint or tired</p><p>- hoarseness, general feeling of being unwell</p><p>- increased energy or activity, unusual breathing pattern<br /><br /><br /><br />&nbsp;</p><p>For more information about this medicinal product, please contact:</p><p>Algorithm SAL&nbsp;</p><p>Tel: +961-9-222050</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p>&nbsp;</p><p><strong>To report any side effect:</strong></p><p>Lebanon and all MENA countries</p><p>Algorithm SAL&nbsp;</p><p>Phone: +961-9-222050 ext. 347</p><p>Fax: +961-9-222604</p><p>Email: pharmacovigilance@algorithm-lb.com</p><p>Website : www.algorithm-lb.com&nbsp;</p><p>Also contact the relevant competent authority.</p><p>&nbsp;</p><p>Saudi Arabia</p><p>Also contact:</p><p>The National Pharmacovigilance Centre (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p>Also contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.</p><p>&bull; Do not store above 30&deg;C. Protect from light and moisture.&nbsp;</p><p>&bull; Store in the original package.</p><p>&bull; Do not use Sinemet<sup>&reg;</sup> after the expiry date stated on the blister and carton. The expiry date refers to the last day of that month.</p><p>&bull; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; The active substances in Sinemet<sup>&reg;</sup> 25/250 mg are 25 mg of carbidopa (in anhydrous form) and 250 mg of levodopa.&nbsp;</p><p>&bull; The active substances in Sinemet<sup>&reg;</sup> 25/100 mg are 25 mg of carbidopa (in anhydrous form) and 100 mg of levodopa.&nbsp;</p><p>&bull; Inactive ingredients are: pregelatinized starch, corn starch, microcrystalline cellulose and magnesium stearate. Sinemet<sup>&reg;</sup> 25/250 mg&nbsp; tablets also contain FD&amp;C Blue #2 (Indigo Carmine). Sinemet<sup>&reg;</sup> 25/100 mg tablets also contain D&amp;C Yellow #10 Aluminum Lake.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                - Sinemet® 25/250 mg are light dapple-blue, biconvex, oval-shaped tablets, one side with a deep angle breakline, the other side engraved “ ALGS275”.
- Sinemet® 25/100 mg are yellow, biconvex, oval-shaped tablets, one side with a deep angle breakline, the other side engraved “ALG S125”.
- Sinemet® 25/250 mg is available in blister packs of 20 tablets.
- Sinemet® 25/100 mg is available in blister packs of 100 tablets.
Not all strengths may be marketed
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder And Final Batch Releaser :&nbsp;</p><p>ALGORITHM S.A.L. Zouk Mosbeh, Lebanon</p><p>Packed by Tabuk Pharmaceutical Manufacturing company Tabuk, Saudi Arabia</p><p>Manufacturer:</p><p>ALGORITHM S.A.L. Zouk Mosbeh, Lebanon</p><p>&nbsp;</p><p><sup>&reg;</sup>Registered Trademark</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                10/2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">&nbsp;يستخدم سينميت<sup>م</sup>&nbsp; لعلاج مرض باركنسون. يحسّن سينميت<sup>م</sup> أعراض مرض باركنسون. مرض باركنسون هو مرض طويل الأمد ينجم عنه ما يلي:&nbsp;</p><p dir="RTL">&bull; بطء في الحركة وعدم استقرار.</p><p dir="RTL">&bull; تشنج في العضلات.</p><p dir="RTL">&bull; ارتعاش (يسمى &ldquo;الرعاش&rdquo;).</p><p dir="RTL">إذا لم يتم علاج مرض باركنسون، قد يصعب عليك مواصلة أنشطتك اليومية العادية.</p><p dir="RTL">يحتوي سينميت<sup>م</sup> على دوائين مختلفين هما: ليفودوبا وكاربيدوبا.</p><p dir="RTL">&bull; ليفودوبا الذي هو حمض أميني عطري يتحول إلى مادة تسمى &ldquo;الدوبامين&rdquo; في دماغك. تساعد مادة الدوبامين في تحسين علامات مرض باركنسون؛</p><p dir="RTL">&bull; ينتمي كاربيدوبا إلى مجموعة من الأدوية تسمى &ldquo;مثبطات ديكاربوكسيلاز الأحماض الأمينية العطرية&rdquo;.</p><p dir="RTL">&nbsp;وهو يساعد ليفودوبا على العمل بفعالية أكبر عن طريق إبطاء سرعة تكسير ليفودوبا في جسمك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تأخذ سينميت<sup>م</sup></strong></p><p dir="RTL">&bull; إذا كانت لديك حساسية (حساسية شديدة) تجاه ليفودوبا أو كاربيدوبا أو تجاه أي من المكونات الأخرى لسينميت<sup>م</sup> (المدرجة في القسم 6).</p><p dir="RTL">&bull; إذا عانيت في الماضي من سرطان الجلد أو كانت لديك أي شامات غير عادية لم يفحصها طبيبك.</p><p dir="RTL">&bull; إذا كنت تتناول أدوية معينة تسمى MAOIs (مثبطات مونوامين أوكسيديز) المستخدمة لعلاج الاكتئاب. يجب أن تتوقف عن استخدام هذه الأدوية قبل أسبوعين على الأقل من بدء تناول سينميت<sup>م</sup> (راجع أيضاً القسم تحت عنوان &ldquo;سينميت<sup>م</sup> والادوية الاخرى&rdquo; أدناه).</p><p dir="RTL">&bull; إذا كنت تعاني من حالة تسمى &ldquo;مرض الجلوكوما ضيقة الزاوية&rdquo; والتي قد تسبب تراكمًا مفاجئًاللضغط في العين.</p><p dir="RTL">&bull; إذا كنت تعاني من اضطراب عقلي شديد.</p><p dir="RTL">&bull; إذا كنتِ حاملاً أو قد تصبحين حاملاً أو مرضعة.</p><p>&nbsp;</p><p dir="RTL">لا تأخذ سينميت<sup>م</sup> إذا كان أي مما سبق ذكره ينطبق عليك. إذا لم تكن متأكدًا، تحدث إلى طبيبك أو الصيدلي قبل تناول سينميت<sup>م</sup>.</p><p>&nbsp;</p><p dir="RTL"><strong>التحذيرات والإحتياطات</strong></p><p dir="RTL"><strong>&nbsp;</strong>راجع طبيبك أو الصيدلي او الممرضة قبل تناول الدواء:&nbsp;</p><p dir="RTL">&bull; إذا كان لديك تاريخ من النوبات (التشنجات).</p><p dir="RTL">&bull; إذا كانت لديك قرحة في أمعائك (&ldquo;قرحة الإثني عشر&rdquo; أو &ldquo;القرحة الهضمية&rdquo;) أو تقيّأتَ دماً.</p><p dir="RTL">&bull; إذا سبق وأصبتَ بنوبة قلبية، أو عانيت من مشاكل في ضربات القلب، أو في الدورة الدموية أو في التنفس.</p><p dir="RTL">&bull; إذا كان لديك مشاكل في الكلى أو الكبد أو الهرمونات.</p><p dir="RTL">&bull; إذا كنتَ تعاني من اكتئاب أو مشاكل عقلية أخرى.</p><p dir="RTL">&bull; إذا كنتَ تعاني من حالة تسمى &ldquo;مرض الجلوكوما ذي الزاوية المفتوحة&rdquo; والتي قد تتسبب في زيادة الضغط في العين. ستحتاج إلى فحوصات منتظمة للضغط في عينك.</p><p dir="RTL">&bull; إذا كنتَ تعاني أحيانًا من نوبات نوم مفاجئة أو تشعر أحيانًا بالنعاس الشديد.</p><p dir="RTL">&bull; إذا أنت على وشك إجراء عملية جراحية.</p><p>&nbsp;</p><p dir="RTL">إذا لم تكن متأكدًا مما إذا كان أي مما سبق ينطبق عليك، راجع طبيبك أو الصيدلي قبل تناول سينميت<sup>م</sup>.</p><p>&nbsp;</p><p>أخبر طبيبك إذا لاحظت أنت أو عائلتك ظهور أعراض شبيهة بالإدمان تؤدي إلى الرغبة الشديدة في تناول جرعات كبيرة من سينميت<sup>م</sup> والأدوية الأخرى المستخدمة في علاج الباركنسون</p><p>&nbsp;</p><p dir="RTL">أخبر طبيبك إذا لاحظت أنت أو عائلتك ظهور تصرفات غير عادية وعدم قدرتك على مقاومة الاندفاع أو الدافع أو الإغراء للقيام بأنشطة معينة قد تضر بها نفسك أو الآخرين. تُعرف هذه الأخيرة باضطرابات السيطرة على الانفعالات ويمكن أن تشمل إدمان القمار أو الإفراط في الأكل أو الإنفاق أو الزيادة غير الطبيعية في الدافع الجنسي أو في الأفكار أو المشاعر الجنسية. قد يحتاج طبيبك إلى مراجعة تفاصيل علاجك.</p><p>&nbsp;</p><p dir="RTL"><strong>سينميت<sup>م</sup> والادوية الاخرى</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">ابلغ طبيبك أو الصيدلي إذا كنت تتناول حاليًا أو سبق وتناولت&nbsp; مؤخّرًا او قد تتناول أيّ أدوية أخرى بما فيها تلك التي حصلت عليها بموجب أو بدون وصفة طبيّة، وتشمل الأدوية العشبية، وذلك لأن سينميت<sup>م</sup> يمكن أن يؤثر على طريقة عمل بعض الأدوية الأخرى والعكس صحيح.&nbsp;</p><p>&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أحد الأدوية التالية:</p><p dir="RTL">&bull; أدوية مرض باركنسون التي تحتوي على ليفودوبا:&nbsp;</p><p dir="RTL">&nbsp; &bull; إذا كانت &laquo;بطيئة الإطلاق&raquo; ، فستحتاج إلى الانتظار 24 ساعة بعد آخر جرعة قبل بدء سينميت<sup>م</sup></p><p dir="RTL">&nbsp; &bull; إذا كانت &laquo;الإطلاق الطبيعي&raquo; ، فستحتاج إلى الانتظار لمدة 12 ساعة بعد آخر جرعة قبل بدء سينميت<sup>م</sup></p><p dir="RTL">&nbsp; &bull; أخبر طبيبك أو الصيدلي حتى لو كنت قد تناولتها في الماضي.</p><p dir="RTL">غالباً ما يستمرّ العديد من مرضى الباركنسون بتناول الأدوية التي لا تحتوي على ليفودوبا بشكلٍ دائم، إلاّ أن الجرعة قد تختلف.</p><p dir="RTL">&bull; أدوية للمشاكل العقلية (بما في ذلك الاكتئاب)، والسلّ، وارتفاع ضغط الدم، وتشنج العضلات، والصرع، أو غيرها من الأمراض المتعلقة بالحركات اللاإرادية. في إحدى هذه الحالات، قد يتم تغيير مقدار جرعتك.</p><p dir="RTL">&bull; أدوية لعلاج نقص الحديد. قد تحتاج إلى أن تغير جرعتك.</p><p dir="RTL">&bull; الأدوية التي تسمى مثبطات الأوكسيداز الأحادي الأمين. (انظر ايضا &laquo;لا تأخذ سينميت<sup>م</sup> &raquo;)</p><p dir="RTL">&bull; الأدوية المضادة للكولين (مثل أورفينادرين، تريهكسيفينيديل، بنزاتروبين، وبروسيكليدين). قد يتم تغيير مقدار جرعتك.</p><p dir="RTL">&bull; الفينيتوين الذي يستخدم لعلاج النوبات (التشنجات)&nbsp;</p><p dir="RTL">&bull; بابافيرين الذي يستخدم لعلاج العجز الجنسي لدى الرجال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تكن متأكدًا مما إذا كان أي مما سبق ينطبق عليك، راجع طبيبك أو الصيدلي قبل تناول هذا الدواء. فلدى طبيبك أو الصيدلي قائمة كاملة من الأدوية التي يجب تجنبها أثناء تناول سينميت<sup>م</sup>.</p><p>&nbsp;</p><p><strong>اختبارات أثناء تناول </strong>سينميت<strong><sup>م</sup></strong></p><p dir="RTL">يمكن أن يؤثر هذا الدواء على بعض الاختبارات الطبية التي قد يقوم بها طبيبك على عينات الدم أو البول. يرجى تذكير طبيبك إذا كنت تتناول سينميت<sup>م</sup> وتجري أي فحوصات.</p><p>&nbsp;</p><p><strong>سينميت<sup>م</sup> مع الطعام والمشروبات</strong></p><p dir="RTL">حاول تجنب تناول أقراص الدواء مع وجبة دسمة. إذا كان نظامك الغذائي يحتوي على الكثير من البروتين (اللحوم والبيض والحليب والجبن)، فقد يؤثّر ذلك على مفعول سينميت<sup>م</sup>، فلا يعمل كما ينبغي.</p><p>&nbsp;</p><p><strong>الحمل والرضاعة</strong></p><p dir="RTL">لا تتناولي سينميت<sup>م</sup> إذا كنت حاملاً، أو قد تصبحين حاملاً أو مرضعة. فإن مادة ليفودوبا، الموجودة في سينميت<sup>م</sup>، تنتقل إلى حليب الأم. اسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء، إذا كنت حاملاً أو مرضعة.</p><p>&nbsp;</p><p><strong>القيادة واستعمال الآلات</strong></p><p dir="RTL">&bull; يؤثر سينميت <sup>م</sup> على أشخاص مختلفين بطرق مختلفة. يعاني بعض الأشخاص من آثار جانبية تؤثر على قدرتهم على القيادة أو استخدام الأدوات أو الآلات (انظر القسم 4 الآثار الجانبية المحتملة). لا تقود السيارة أو تستخدم الأدوات أو الآلات إذا حصلت هذه التأثيرات.</p><p>&nbsp;</p><p dir="RTL">&bull; يمكن ان يجعلك سينميت <sup>م</sup> تشعر بالنعاس أو يسبب &laquo;نوبات نوم مفاجئة&raquo;. إذا حدث هذا لك ، فلا يجوز لك القيادة أو استخدام الأدوات أو الآلات. سيخبرك طبيبك إذا كان بإمكانك البدء في القيادة مرة أخرى إذا توقفت هذه النوبات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هذا الدواء وفقاً لتعليمات طبيبك تماماً. يجب عليك مراجعة طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p><strong>تناول هذا الدواء</strong></p><p dir="RTL">&bull; إذا انكسر القرص عند إخراجه من العبوة، تأكد من حصولك على جميع قطع القرص (الجرعة الكاملة). إذا لم يكن لديك كل قطع القرص المكسور، فتخلص من القطع وخذ قرصًا آخر من العبوة.</p><p dir="RTL">&bull; قد يؤدي تناول جزء فقط من القرص (جرعة جزئية) إلى تفاقم الأعراض</p><p dir="RTL">&bull; تناول هذا الدواء عن طريق الفم.</p><p dir="RTL">&bull;على الرغم من ان هذا الدواء يمكن ان يكون له تأثير بعد يوم واحد، إلا أنه قد يستغرق حتى سبعة أيام ليظهر مفعوله.</p><p dir="RTL">&bull; تناول أقراصك على فترات منتظمة وفقاً لتعليمات طبيبك.</p><p dir="RTL">&bull; لا تغير الأوقات التي تتناول فيها أقراصك أو تتناول أي أدوية أخرى لمرض باركنسون من دون استشارة طبيبك أولاً.</p><p dir="RTL">&bull; تجنب تناول أقراصك مع وجبة دسمة.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا كانت أوّل مرة تتناول فيها ليفودوبا :</strong></p><p dir="RTL">تكون جرعة البدء المعتادة:</p><p dir="RTL">&bull; سينميت<sup>م</sup> ٢٥/١٠٠ ملغ: قرص واحد ثلاث مرات في اليوم.</p><p>&nbsp;</p><p><strong>إذا كنت قد تناولت ليفودوبا من قبل</strong></p><p dir="RTL">&bull; سيطلب منك طبيبك التوقف عن تناول دوائك قبل أن تبدأ في تناول سينميت<sup>م</sup>.</p><p dir="RTL">جرعة البدء المعتادة هي:</p><p dir="RTL">&bull; سينميت<sup>م</sup> ٢٥/١٠٠ ملغ&nbsp; و سينميت<sup>م </sup>٢٥ /٢٥٠ ملغ: قرص واحد ثلاث او اربع مرات في اليوم.</p><p>&nbsp;</p><p dir="RTL">قد يصف طبيبك أكثر من جرعة واحدة من&nbsp; سينميت<sup>م</sup>. إذا تم إعطاؤك أقراص سينميت<sup>م</sup> مختلفة لتتناولها ، فتأكد من أنك تتناول القرص الصحيح في الوقت المناسب.</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>الاستخدام عند الأطفال والمراهقين</strong></p><p dir="RTL">&nbsp;سينميت<sup>م</sup> غير مناسب للأطفال الذين تقل أعمارهم عن 18 عامًا.</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p><strong>إذا أخذت كميّة من سينميت<sup>م</sup> أكثر مما ينبغي</strong></p><p dir="RTL">إذا تناولت الكثير من الأقراص، راجع طبيبك على الفور.</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p><strong>إذا نسيت أخذ سينميت<sup>م</sup></strong></p><p dir="RTL">لا تأخذ جرعة مضاعفة للتعويض عن القرص الذي نسيت أخذه.&nbsp;</p><p>&nbsp;</p><p>إذا توقفت عن تناول سينميت<sup>م</sup></p><p dir="RTL">لا تتوقف عن تناول سينميت<sup>م</sup> ولا تغيّر مقدار جرعتك من دون التحدث إلى طبيبك أولاً. عند التوقف عن تناول سينميت<sup>م</sup> يمكن أن يحدث ما يلي: تصلب العضلات وارتفاع درجة الحرارة (الحمى) واضطرابات عقلية.</p><p dir="RTL">إذا كانت لديك أي أسئلة أخرى حول استخدام هذا المنتج، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل سائرالأدوية، يمكن أن يسبّب سينميت<sup>م</sup> أعراضاً جانبيّة لا تحدث مع المرضى كلّهم.&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>توقف عن تناول سينميت<sup>م</sup> واستشر طبيبك على الفور إذا لاحظت أيًا من الأعراض الجانبية التالية:</strong></p><p dir="RTL">&bull; رد فعل تحسسي ، العلامات قد تشمل الشرى (طفح جلدي) ،حكة ، طفح جلدي ، تورم في وجهك أوالشفتين أواللسان أو الحلق. هذا قد يسبب صعوبة في التنفس أو البلع</p><p dir="RTL">&bull; ألم صدر</p><p dir="RTL">&bull; عدم انتظام ضربات القلب أو خفقان القلب</p><p dir="RTL">&bull; دوار عند الوقوف بسرعة</p><p dir="RTL">&bull; نزيف من أمعائك والذي قد يظهر على شكل دم في برازك أو براز الداكن (نزيف الجهاز الهضمي)</p><p dir="RTL">&bull; مشاكل في الدم ، العلامات قد تشمل شحوب الجلد، التعب والحمى وإلتهاب الحلق أو كدمات خفيفة و نزيف طويل بعد الاصابة</p><p dir="RTL">&bull; تيبس العضلات ، ارتفاع في درجة الحرارة</p><p dir="RTL">&bull; التغيرات العقلية بما في ذلك الأوهام والهلوسة وكآبة</p><p dir="RTL">&bull; نوبات (تشنجات).</p><p>&nbsp;</p><p><strong>الآثار الجانبية الأكثر شيوعًا هي</strong></p><p dir="RTL">&bull; حركات غير طبيعية مثل الوخز أو التشنجات (والتي قد تكون أو لا تشبه أعراض مرض باركنسون)</p><p dir="RTL">&bull; غثيان</p><p dir="RTL">&bull; التهابات المسالك البولية</p><p><strong>تشمل الآثار الجانبية الأ</strong></p><p dir="RTL">&bull; إغماء ، فقدان الشهية ، إرتفاع ضغط الدم</p><p dir="RTL">&bull; التهاب الأوردة ، والإسهال (القيء) وتلون البول أو العرق أو اللعاب</p><p dir="RTL">&bull; ظاهرة التشغيل المتقطع ، المميزة لبعض الأشخاص المصابين بمرض باركنسون طويل الأمد. هذا عندما يحصل تغييرات غير متوقعة من كونها متنقلة - &laquo;تشغيل&raquo; &ndash; إلى عدم القدرة المفاجئة على التحرك - &laquo;إيقاف&raquo;. يمكن أن يحدث &laquo;إيقاف&raquo; إلى &laquo;تشغيل&raquo; فقط فجأة.</p><p dir="RTL">&bull; دوخة ونعاس (بما في ذلك النعاس المفرط أو نوبات بداية النوم المفاجئ) والدبابيس والإبر</p><p dir="RTL">&bull; تشوهات الحلم ، والارتباك ، والشعور بالقلق ، والقصرفي التنفس ، تساقط الشعر</p><p>&nbsp;</p><p dir="RTL"><strong>قد تواجه الأعراض الجانبية التالية:</strong></p><p dir="RTL">&bull; التوق لجرعات كبيرة من سينميت<sup>م</sup> تزيد عن الجرعات المطلوبة للسيطرة على الأعراض الحركية ، والمعروفة باسم الدوبامين متلازمة خلل التنظيم. يعاني بعض المرضى من أعراض حركات لا إرادية شديدة غير طبيعية (خلل الحركة) ، تقلبات مزاج أو آثار جانبية أخرى بعد تناول جرعات كبيرة من سينميت<sup>م</sup></p><p dir="RTL">&bull; عدم القدرة على مقاومة الدافع للقيام بعمل يمكن أن يكون ضار ، والذي قد يشمل:</p><p dir="RTL">&nbsp;&bull; دافع قوي للمقامرة بشكل مفرط بالرغم من عواقب شخصية أو عائلية</p><p dir="RTL">&nbsp;&bull; تغيير أو زيادة الاهتمام الجنسي و السلوك الذي ممكن ان يكون مصدر قلق كبير لك أو للآخرين ، على سبيل المثال زيادة الدافع الجنسي</p><p dir="RTL">&nbsp;&bull; التسوق أو الإنفاق المفرط الذي لا يمكن السيطرة عليه</p><p dir="RTL">&nbsp;&bull; الأكل&nbsp; بشراهة (تناول كميات كبيرة من الطعام في وقت قصير) أو الأكل القهري (تناول طعام أكثر من المعتاد وأكثر مما هو مطلوب لإشباع جوعك).</p><p>&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك إذا واجهت أيًا من هذه السلوكيات ؛ سيناقش طرق الإدارة أو التقليل&nbsp; من الأعراض.</strong></p><p>&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية التي تم الإبلاغ عنها مع الأدوية التي تحتوي على ليفودوبا.</strong></p><p>قد يتم اختبار هذه عند تناول&nbsp; سينميت<sup>م</sup></p><p>&nbsp;</p><p dir="RTL">الجهاز العصبي:</p><p dir="RTL">&bull; فقدان السيطرة على الحركات الإرادية اليومية</p><p dir="RTL">&bull; خدر ، زيادة رعشة اليد ، ارتعاش العضلات ، تقلصات عضلية ، حركة غير منتظمة لعضلات الفك الناتجة في صعوبة فتح الفم</p><p dir="RTL">&bull; صعوبة النوم ، الشعور بالقلق أو الانتشاء ، السقوط وأنماط مشي غير طبيعية</p><p dir="RTL">&bull; صداع الراس</p><p>&nbsp;</p><p dir="RTL">عيون:</p><p dir="RTL">&bull; تدلي الجفن واتساع حدقة العين</p><p dir="RTL">&bull; تغيرات في الرؤية ، عدم انتظام حركة العين</p><p>&nbsp;</p><p dir="RTL">الجهاز الهضمي:</p><p dir="RTL">&bull; عسر الهضم ، جفاف الفم ، طعم مر</p><p dir="RTL">&bull; انتفاخ الغدد اللعابية ، صعوبة في البلع وطحن الأسنان</p><p dir="RTL">&bull; الفواق وآلام البطن والضيق والإمساك والرياح</p><p dir="RTL">&bull; حرقان في اللسان.</p><p>&nbsp;</p><p dir="RTL">الصحة الجنسية:</p><p dir="RTL">&bull; الانتصاب غير الطبيعي المستمر للقضيب</p><p>&nbsp;</p><p dir="RTL">الجهاز البولي:</p><p dir="RTL">&bull; صعوبة التبول أو سلس البول (عدم القدرة على التحكم في تدفق البول)</p><p>&nbsp;</p><p dir="RTL">جلد:</p><p>&bull; تغير بقع الجلد المصطبغة ، بما في ذلك ، الشامات غير المنتظمة &nbsp; او المتهيجة ، أو الشامات التي&nbsp; حصلت لها تغييرات (الورم الميلانيني)</p><p>&nbsp;</p><p dir="RTL">عام:</p><p dir="RTL">&bull; زيادة الوزن أو فقدانه ، انتفاخ في الأطراف</p><p dir="RTL">&bull; احمرار ، هبات ساخنة ، تعرق متزايد</p><p dir="RTL">&bull; الشعور بالضعف أو الإغماء أو التعب</p><p dir="RTL">&bull; بحة في الصوت ، شعور عام بالتوعك</p><p dir="RTL">&bull; زيادة الطاقة أو النشاط ، نمط تنفس غير معتاد<br /><br /><br /><br />&nbsp;</p><p dir="RTL">للمزيد من المعلومات حول هذا الدواء، الرجاء الاتصال بـ:</p><p dir="RTL">ألغوريتم ش.م.ل.</p><p>هاتف: 222050-9-961+</p><p>&nbsp;</p><p><strong>الإفادة عن الأعراض الجانبية</strong></p><p dir="RTL">إذا ظهرت لديك أي أعراض جانبية، تحدث إلى طبيبك أو الصيدلي. يشمل ذلك أي أعراض جانبية محتملة غير مذكورة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الأعراض الجانبية مباشرةً عبر:</p><p>&nbsp;</p><p dir="RTL"><strong>للإفادة عن أيّ أعراض جانبيّة:</strong></p><p>لبنان وكلّ بلدان الشرق الأوسط وشمال إفريقيا</p><p>ألغوريتم ش.م.ل</p><p>هاتف: 222050-9-961+ الرقم الداخلي: 347</p><p>فاكس: &nbsp; ٢٢٢٦٠٤-٩-٩٦١+&nbsp;</p><p>البريد الإلكتروني: pharmacovigilance@algorithm-lb.com</p><p>الموقع الإلكتروني: www.algorithm-lb.com&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">المملكة العربيّة السعوديّة</p><p dir="RTL">الرجاء الاتصال كذلك بـ:</p><p dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية (NPC):</p><p dir="RTL">&nbsp;</p><p dir="RTL">مركز إتصال الهيئة العامة للغذاء والدواء: ١٩٩٩٩</p><p dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL">الرجاء الإتّصال كذلك بالسّلطة المختصّة</p><p dir="RTL">للمزيد من المعلومات حول هذا الدواء، الرجاء الاتصال بـ:</p><p dir="RTL">ألغوريتم ش.م.ل.</p><p>هاتف: 222050-9-961+</p><p>&nbsp;</p><p><strong>الإفادة عن الأعراض الجانبية</strong></p><p dir="RTL">إذا ظهرت لديك أي أعراض جانبية، تحدث إلى طبيبك أو الصيدلي. يشمل ذلك أي أعراض جانبية محتملة غير مذكورة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الأعراض الجانبية مباشرةً عبر:</p><p>&nbsp;</p><p dir="RTL"><strong>للإفادة عن أيّ أعراض جانبيّة:</strong></p><p>لبنان وكلّ بلدان الشرق الأوسط وشمال إفريقيا</p><p>ألغوريتم ش.م.ل</p><p>هاتف: 222050-9-961+ الرقم الداخلي: 347</p><p>فاكس: &nbsp; ٢٢٢٦٠٤-٩-٩٦١+&nbsp;</p><p>البريد الإلكتروني: pharmacovigilance@algorithm-lb.com</p><p>الموقع الإلكتروني: www.algorithm-lb.com&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">المملكة العربيّة السعوديّة</p><p dir="RTL">الرجاء الاتصال كذلك بـ:</p><p dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية (NPC):</p><p dir="RTL">&nbsp;</p><p dir="RTL">مركز إتصال الهيئة العامة للغذاء والدواء: ١٩٩٩٩</p><p dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL">الرجاء الإتّصال كذلك بالسّلطة المختصّة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; يُحفظ بعيدًا عن متناول الأطفال ونظرهم. يُحفظ في درجات حرارة لا تتعّدى 30 درجة مئويّة. يحفظ بعيداً عن الضوء والرطوبة.</p><p>.يُحفظ في العبوة الأساسية.&nbsp;</p><p dir="RTL">&bull; لا تستعمل أقراص سينميت<sup>م</sup> بعد انقضاء تاريخ الصلاحيّة المذكور على علبة الكرتون والظروف. يشير تاريخ انتهاء الصلاحيّة إلى اليوم الأخير من الشهر المذكور.&nbsp;</p><p dir="RTL">&bull; لا ترمِ أي دواء في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;المواد الفعالة في أقراص سينميت<sup>م</sup> 25/250 ملغرام هي 25 ملغرام من كاربيدوبا (في شكل لا مائي) و 250 ملغرام من ليفودوبا.</p><p dir="RTL">&bull;المواد الفعالة في أقراص سينميت<sup>م</sup> 25/100 ملغرام هي 25 ملغرام من كاربيدوبا (في شكل لا مائي) و 100 ملغرام من ليفودوبا.</p><p dir="RTL">&bull;المكونات غير الفعالة هي: نشا ما قبل الجيلاتين، نشا الذرة، سليلوز دقيق التبلور، وستيرات المغنيسيوم. تحتوي أقراص سينميت<sup>م</sup> 25/250 ملغرام أيضًا على FD&amp;C Blue #2&nbsp; (أنديجو كارمين) في حين تحتوي أقراص سينميت<sup>م</sup> 25/100 ملغرام أيضًا على D&amp;C Yellow #10&nbsp; (ألومنيوم ليك).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-أقراص سينميت<sup>م</sup> 25/250 ملغرام، هي أقراص ذات لون أزرق فاتح، بيضاويّة الشكل وثنائيّة التحدّب، تتميّز بخط فاصل بزاوية عميقة من جهة، ومن جهة أخرى محفور عليها &ldquo;ALG S275&rdquo;.</p><p dir="RTL">-أقراص سينميت<sup>م</sup> 25/100 ملغرام، هي أقراص صفراء اللون، بيضاويّة الشكل وثنائيّة التحدّب، تتميّز بخط فاصل بزاوية عميقة من جهة، ومن جهة أخرى محفور عليها &ldquo;ALG S125&rdquo;.</p><p dir="RTL">-يأتي سينميت<sup>م</sup> 25/250 ملغرام في علبة تحتوي على 20 قرصٍ.&nbsp;</p><p dir="RTL">-يأتي سينميت<sup>م</sup> 25/100 ملغرام في علبة تحتوي على 100 قرصٍ.&nbsp;</p><p>&nbsp;</p><p dir="RTL">لم يتمّ تحديد جميع العيارات في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك رخصة التسويق والمصنع المسؤول عن تحرير الصنف:</p><p>ألغوريتم ش.م.ل. ذوق مصبح، لبنان</p><p>&nbsp;</p><p>معبأة من قبل شركة تبوك للصناعات الدوائية تبوك، المملكة العربيّة السعوديّة</p><p>&nbsp;</p><p>الشركة المصنّعة</p><p>&nbsp;ألغوريتم ش.م.ل. ذوق مصبح، لبنان</p><p>&nbsp;</p><p dir="RTL">&nbsp;م ماركة مسجلة. &nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            .10/2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sinemet® 25 mg/250 mg tablets
Sinemet® 25 mg/100 mg tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet of Sinemet® 25 mg/250 mg contains Carbidopa (equivalent to 25 mg of anhydrous Carbidopa) and 250 mg levodopa.
Each tablet of Sinemet® 25 mg/100 mg contains Carbidopa (equivalent to 25 mg of anhydrous Carbidopa) and 100 mg levodopa.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sinemet® 25 mg/250 mg are light dapple‐blue, biconvex, oval shaped tablets, one side with a deep angle breakline, the other side engraved “ALG S275”.

Sinemet® 25 mg/100 mg are yellow, biconvex, oval shaped tablets, one side with a deep angle breakline, the other side engraved “ALG S125”.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Antiparkinson agent.</p><p>Treatment of Parkinson&#39;s disease, Sinemet<sup>&reg;</sup> frequently is helpful in the management of tremor, dysphagia, sialorrhea and postural instability associated with Parkinson&#39;s disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>The optimum daily dosage of &#39;Sinemet&#39; must be determined by careful titration in each patient.</p><p>&#39;Sinemet&#39; Tablets are available in a ratio of 1:4 or 1:10 of carbidopa to levodopa to provide facility for fine dosage titration for each patient.</p><p>&nbsp;</p><p><strong>General Considerations</strong></p><p>Studies show that the peripheral dopa-decarboxylase is fully inhibited (saturated) by carbidopa at doses between 70 and100 mg a day. Patients receiving less than this amount of carbidopa are more likely to experience nausea and vomiting.</p><p>&nbsp;</p><p>Standard antiparkinsonian drugs, other than levodopa alone, may be continued while &#39;Sinemet&#39; is being administered, although their dosage may have to be adjusted.</p><p>&nbsp;</p><p>Because both therapeutic and adverse effects are seen more rapidly with &#39;Sinemet&#39; than with levodopa, patients should be carefully monitored during the dosage adjustment period. Involuntary movements, particularly blepharospasm, are a useful early sign of excess dosage in some patients.</p><p>&nbsp;</p><p><strong>Patients not receiving levodopa</strong></p><p>Dosage may be best initiated with one tablet of &#39;Sinemet 25 mg/100 mg&#39; three times a day. This dosage schedule provides 75 mg of carbidopa per day. Dosage may be increased by one tablet of &#39;Sinemet 25 mg/100 mg&#39; every day or every other day, as necessary, until a dosage equivalent of eight tablets of &#39;Sinemet 25 mg/100 mg&#39; a day is reached.</p><p>&nbsp;</p><p>Response has been observed in one day, and sometimes after one dose. Fully effective doses usually are reached within seven days as compared to weeks or months with levodopa alone.</p><p>&nbsp;</p><p><strong>Patients receiving levodopa</strong></p><p>Discontinue levodopa at least 12 hours (24 hours for slow-release preparations) before starting therapy with &#39;Sinemet&#39;. The easiest way to do this is to give &#39;Sinemet&#39; as the first morning dose after a night without any levodopa. The dose of &#39;Sinemet&#39; should be approximately 20% of the previous daily dosage of levodopa.</p><p>&nbsp;</p><p>Patients taking less than 1,500 mg levodopa a day should be started on one tablet of &#39;Sinemet 25 mg/100 mg&#39; three or four times a day dependent on patient need. The suggested starting dose for most patients taking more than 1,500 mg levodopa a day is one tablet of &#39;Sinemet 25 mg/250 mg&#39; three or four times a day.</p><p>&nbsp;</p><p><strong>Maintenance</strong></p><p>Therapy with &#39;Sinemet&#39; should be individualized and adjusted gradually according to response.</p><p>&nbsp;</p><p>When more levodopa is required, &#39;Sinemet 25 mg/250 mg Tablets&#39; should be substituted at a dosage of one tablet three or four times a day. If necessary, the dosage of &#39;Sinemet 25 mg/250 mg Tablets&#39; may be increased by one tablet everyday or every other day to a maximum of eight tablets a day. Experience with a total daily dosage greater than 200 mg carbidopa is limited.</p><p>&nbsp;</p><p><strong>Patients receiving levodopa with another decarboxylase inhibitor.</strong></p><p><strong>&nbsp;</strong></p><p>When transferring a patient to &#39;Sinemet&#39; from levodopa combined with another decarboxylase inhibitor, discontinue dosage at least 12 hours before &#39;Sinemet&#39; is started. Begin with a dosage of &#39;Sinemet&#39; that will provide the same amount of levodopa as contained in the other levodopa/decarboxylase inhibitor combination.</p><p>&nbsp;</p><p><strong>Patients receiving other antiparkinsonian agents</strong></p><p>Current evidence indicates that other antiparkinsonian agents may be continued when &#39;Sinemet&#39; is introduced, although dosage may have to be adjusted in line with manufacturers recommendations.</p><p>&nbsp;</p><p><strong>Paediatric population</strong></p><p>The safety and efficacy of &#39;Sinemet&#39; in children under 18 years of age has not been established and its use in patients below the age of 18 is not recommended.</p><p>&nbsp;</p><p><strong>Elderly</strong></p><p>There is wide experience in the use of this product in elderly patients. The recommendations set out above reflect the clinical data derived from this experience.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>For oral use.</p><p>&nbsp;</p><p>If a tablet breaks when it is removed from the packaging, it should only be consumed if the whole dose can be taken. If it cannot, the pieces of the broken tablet should be discarded and another tablet taken from the packaging.</p><p>&nbsp;</p><p>Administration of a partial dose may result in worsening of symptoms.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Non-selective monoamine oxidase (MAO) inhibitors are contraindicated for use with 'Sinemet'. These inhibitors must be discontinued at least two weeks before starting 'Sinemet'. 'Sinemet' may be administered concomitantly with the manufacturer's recommended dose of an MAO inhibitor with selectivity for MAO type B (e.g. selegiline hydrochloride).(See section 4.5 'Interaction with other medicinal products and other forms of interaction'.)
Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1.
'Sinemet' is contraindicated in patients with narrow-angle glaucoma.
Since levodopa may activate a malignant melanoma, it should not be used in patients with suspicious undiagnosed skinlesions or a history of melanoma.
Use in patients with severe psychoses.
See also section 4.6 'Fertility, pregnancy and lactation'.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&#39;Sinemet&#39; is not recommended for the treatment of drug-induced extrapyramidal reactions.</p><p>&#39;Sinemet&#39; should be administered cautiously to patients with severe cardiovascular or pulmonary disease, bronchial asthma, renal, hepatic or endocrine disease, or history of peptic ulcer disease (because of the possibility of upper gastro-intestinal haemorrhage).</p><p>Care should be exercised when &#39;Sinemet&#39; is administered to patients with a history of myocardial infarction who have residual atrial nodal, or ventricular arrhythmias. Cardiac function should be monitored with particular care in such patients during the period of initial dosage adjustment.</p><p>Levodopa has been associated with somnolence and episodes of sudden sleep onset. Sudden onset of sleep during daily activities, in some cases without awareness or warning signs, has been reported very rarely. Patients must be informed of this and advised to exercise caution while driving or operating machines during treatment with levodopa. Patients who have experienced somnolence and/or an episode of sudden sleep onset must refrain from driving or operating machines. Furthermore a reduction of dosage or termination of therapy may be considered.</p><p>All patients should be monitored carefully for the development of mental changes, depression with suicidal tendencies,and other serious antisocial behaviour. Patients with current psychoses should be treated with caution.</p><p>Dyskinesias may occur in patients previously treated with levodopa alone because carbidopa permits more levodopa toreach the brain and, thus, more dopamine to be formed. The occurrence of dyskinesias may require dosage reduction.</p><p>As with levodopa, &#39;Sinemet&#39; may cause involuntary movements and mental disturbances. Patients with a history of severe involuntary movements or psychotic episodes when treated with levodopa alone should be observed carefully when &#39;Sinemet&#39; is substituted. These reactions are thought to be due to increased brain dopamine following administration of levodopa, and use of &#39;Sinemet&#39; may cause a recurrence. A syndrome resembling the neuroleptic malignant syndrome including muscular rigidity, elevated body temperature, mental changes and increased serum creatine phosphokinase has been reported with the abrupt withdrawal of antiparkinsonian agents. Therefore, any abrupt dosage reduction or withdrawal of &#39;Sinemet&#39; should be carefully observed, particularly in patients who are also receiving neuroleptics.</p><p>Concomitant administration of psycho-active drugs such as phenothiazines or butyrophenones should be carried out with caution, and the patient carefully observed for loss of antiparkinsonian effect. Patients with a history of convulsions should be treated with caution.</p><p>As with levodopa, periodic evaluation of hepatic, haematopoetic, cardiovascular and renal function are recommended during extended therapy.</p><p>Patients with chronic wide-angle glaucoma may be treated cautiously with &#39;Sinemet&#39;, provided the intra-ocular pressure is well controlled and the patient monitored carefully for changes in intra-ocular pressure during therapy.</p><p>If general anaesthesia is required, therapy with &#39;Sinemet&#39; may be continued for as long as the patient is permitted to take fluids and medication by mouth. If therapy has to be stopped temporarily, &#39;Sinemet&#39; may be restarted as soon as oral medication can be taken at the same daily dosage as before.</p><p>Epidemiological studies have shown that patients with Parkinson&#39;s disease have a higher risk of developing melanoma than the general population (approximately 2-6 fold higher). It is unclear whether the increased risk observed was due to Parkinson&#39;s disease, or other factors such as drugs used to treat Parkinson&#39;s disease. Therefore patients and providers&nbsp; are advised to monitor for melanomas on a regular basis when using &#39;Sinemet&#39; for any indication. Ideally, periodic skin examinations should be performed by appropriately qualified individuals (e.g., dermatologists).</p><p><strong>Laboratory Tests</strong></p><p>Commonly, levels of blood urea nitrogen, creatinine, and uric acid are lower during administration of &#39;Sinemet&#39; than with levodopa. Transient abnormalities include elevated levels of blood urea, AST (SGOT), ALT (SGPT), LDH, bilirubin, andalkaline phosphatase.</p><p>Decreased haemoglobin, haematocrit, elevated serum glucose and white blood cells, bacteria and blood in the urine have been reported.</p><p>Positive Coombs&#39; tests have been reported, both with &#39;Sinemet&#39; and levodopa alone.</p><p>&#39;Sinemet&#39; may cause a false positive result when a dipstick is used to test for urinary ketone; and this reaction is not altered by boiling the urine. The use of glucose oxidase methods may give false negative results for glycosuria.</p><p>Dopamine Dysregulation Syndrome (DDS) is an addictive disorder resulting in excessive use of the product seen in some patients treated with carbidopa/ levodopa. Before initiation of treatment, patients and caregivers should be warnedof the potential risk of developing DDS (see also section 4.8).</p><p><u>Impulse control disorders</u></p><p>Patients should be regularly monitored for the development of impulse control disorders. Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments containing levodopa including Sinemet. Review of treatment is recommended if such symptoms develop.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Caution should be exercised when the following drugs are administered concomitantly with &#39;Sinemet&#39;.</p><p><strong>Antihypertensive agents</strong></p><p>Postural hypotension can occur when &#39;Sinemet&#39; is added to the treatment of patients already receiving antihypertensive drugs. Dosage adjustment of the antihypertensive agent may be required.</p><p><strong>Antidepressants</strong></p><p>Rarely, reactions including hypertension and dyskinesia have been reported with the concomitant use of tricyclic antidepressants (see first paragraph of section 4.3 &#39;Contraindications&#39; for patients receiving MAOIs).</p><p>&nbsp;</p><p><strong>Anticholinergics</strong></p><p>Anticholinergics may affect the absorption and thus the patient&#39;s response.</p><p><strong>Iron</strong></p><p>Studies demonstrate a decrease in the bioavailability of carbidopa and/or levodopa when it is ingested with ferrous sulphate or ferrous gluconate.</p><p><strong>Other drugs</strong></p><p>To date there has been no indication of interactions that would preclude concurrent use of standard antiparkinsonian drugs.</p><p>Dopamine D2 receptor antagonists (e.g. phenothiazines, butyrophenones, and risperidone) and isoniazid, may reduce the therapeutic effects of levodopa. The beneficial effects of levodopa in Parkinson&#39;s disease have been reported to be reversed by phenytoin and papaverine. Patients taking these drugs with &#39;Sinemet&#39; should be carefully observed for loss of therapeutic response.</p><p>Use of &#39;Sinemet&#39; with dopamine-depleting agents (e.g., tetrabenazine) or other drugs known to deplete monoamine stores is not recommended.</p><p>Concomitant therapy with selegiline and carbidopa-levodopa may be associated with severe orthostatic hypotension not attributable to carbidopa-levodopa alone (see section 4.3 &#39;Contraindications&#39;).</p><p>Since levodopa competes with certain amino acids, the absorption of &#39;Sinemet&#39; may be impaired in some patients on a high protein diet.</p><p>The effect of simultaneous administration of antacids with &#39;Sinemet&#39; on the bioavailability of levodopa has not been studied.</p><p>&#39;Sinemet&#39; may be given to patients with Parkinson&#39;s disease and syndrome who are taking vitamin preparations that contain pyridoxine hydrochloride (Vitamin B6). Caution should be exercised when the following drugs are administered concomitantly with Sinemet<sup>&reg;</sup>:</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>&nbsp;Pregnancy</u></p><p>Although the effects of &#39;Sinemet&#39; on human pregnancy are unknown, both levodopa and combinations of carbidopa andlevodopa have caused visceral and skeletal malformations in rabbits. Therefore, the use of &#39;Sinemet&#39; in women ofchildbearing potential requires that the anticipated benefits of the drug be weighed against possible hazards shouldpregnancy occur.</p><p><u>Breast-feeding</u></p><p>It is not known whether carbidopa is excreted in human milk. In a study of one nursing mother with Parkinson&#39;s disease, excretion of levodopa in human breast milk was reported. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in infants, a decision should be made whether to discontinue breast-feeding or discontinue the use of &#39;Sinemet&#39;, taking into account the importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Individual responses to medication may vary and certain side effects that have been reported with &#39;Sinemet&#39; may affect some patients&#39; ability to drive or operate machinery. Patients treated with levodopa and presenting with somnolence and/or sudden sleep episodes must be informed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e.g. operating machines), until such recurrent episodes and somnolence have resolved (see also section 4.4 &#39;Special warnings and precautions for use&#39;).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Side effects that occur frequently with &#39;Sinemet&#39; are those due to the central neuropharmacological activity of dopamine. These reactions can usually be diminished by dosage reduction. The most common are dyskinesias including choreiform, dystonic and other involuntary movements and nausea. Muscle twitching and blepharospasm may be taken as early signs to consider dosage reduction.</p><p>Other side effects reported in clinical trials or in post-marketing experience include:</p><p>Infections and infestations:</p><p>urinary tract infections (frequency: very common)</p><p>Body as a whole: syncope, chest pain, anorexia.</p><p>Cardiovascular: cardiac irregularities and/or palpitations, orthostatic effects including hypotensive episodes, hypertension, phlebitis.</p><p>Gastro-intestinal: vomiting, , gastro-intestinal bleeding, development of duodenal ulcer, diarrhoea, dark saliva.</p><p>Haemotologic: leucopenia, haemolytic and non-haemolytic anaemia, thrombocytopenia, agranulocytosis.</p><p>Hypersensitivity: angioedema, urticaria, pruritus, Henoch-Schonlein purpura.</p><p>Nervous System/Psychiatric: neuroleptic malignant syndrome (see section 4.3 &#39;Contraindications&#39;), bradykinetic episodes(the &ldquo;on-off&rdquo; phenomenon), dizziness, paraesthesia, psychotic episodes including delusions, hallucinations and paranoidideation, depression with or without development of suicidal tendencies, dementia, dream abnormalities, agitation, confusion, increased libido. Levodopa is associated with somnolence and has been associated very rarely with excessive daytime somnolence and sudden sleep onset episodes.</p><p>Respiratory: dyspnoea.</p><p>Skin: alopecia, rash, dark sweat.</p><p>Urogenital: dark urine.</p><p>Rarely convulsions have occurred; however, a causal relationship with &#39;Sinemet&#39; has not been established.</p><p>Other side effects that have been reported with levodopa or levodopa/carbidopa combinations and may be potential side effects with &#39;Sinemet&#39; include:</p><p><em><s>&nbsp;</s></em></p><p>Gastro-intestinal: dyspepsia, dry mouth, bitter taste, sialorrhoea, dysphagia, bruxism, hiccups, abdominal pain and distress, constipation, flatulence, burning sensation of the tongue.</p><p>Metabolic: weight gain or loss, oedema.</p><p>Nervous System/Psychiatric: asthenia, decreased mental acuity, disorientation, ataxia, numbness, increased hand tremor, muscle cramp, trismus, activation of latent Horner&#39;s syndrome, insomnia, anxiety, euphoria, falling, gait abnormalities and Dopamine Dysregulation Syndrome.</p><p><em>&nbsp;</em></p><p><u>Description of selected adverse reactions</u></p><p>Dopamine Dysregulation Syndrome (DDS) is an addictive disorder seen in some patients treated with carbidopa/levodopa. Affected patients show a compulsive pattern of dopaminergic drug misuse above doses adequate to control motor symptoms, which may in some cases result in severe dyskinesias (see also section 4.4).</p><p><u>Impulse control disorders</u></p><p>Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments containing levodopa including Sinemet (see section 4.4. &#39;Special warnings and precautions for use&#39;).</p><p>Skin: flushing, increased sweating.</p><p>Special senses: diplopia, blurred vision, dilated pupils, oculogyric crises.</p><p>Urogenital: urinary retention, urinary incontinence, priapism.</p><p>Miscellaneous: weakness, faintness, fatigue, headache, hoarseness, malaise, hot flushes, sense of stimulation, bizarre breathing patterns, malignant melanoma (see section 4.3 &#39;Contraindications&#39;).</p><p>&nbsp;</p><p>To report any side effect(s):</p><p><strong>&nbsp;</strong></p><p>Saudi Arabia: National Pharmacovigilance and Drug Safety Center (NPC)</p><p>&nbsp;</p><p>&middot; SFDA call center: 19999</p><p>&middot; Email: npc.drug@sfda.gov.sa</p><p>&middot; Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Treatment:</strong></p><p>Management of acute overdosage with Sinemet<sup>&reg;</sup> is basically the same as management of acute overdosage with levodopa; however, pyridoxine is not effective in reversing the actions of Sineme<sup>t&reg;. </sup>General supportive measures should be employed along with immediate gastric lavage. Intravenous fluids should be administered judiciously and an adequate airway maintained. Electrocardiographic monitoring should be instituted and the patient observed carefully for the development of arrhythmias; if required, appropriate antiarrhythmic therapy should be given. The possibility that the patient may have taken other drugs as well as Sinemet<sup>&reg;</sup> should be taken into consideration. To date, no experience has been reported with dialysis; hence, its value in overdosage is not known.</p><p>The terminal half-life of levodopa is about two hours in the presence of carbidopa.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Anti-Parkinson drugs</p><p>ATC code: N04BA02</p><p><u>Mechanism of action</u></p><p>Levodopa is a precursor of dopamine, and is given as replacement therapy in Parkinson&#39;s disease.</p><p>Carbidopa is a peripheral dopa decarboxylase inhibitor. It prevents metabolism of levodopa to dopamine in the peripheral circulation, ensuring that a higher proportion of the dose reaches the brain, where dopamine acts. A lower dose of levodopa can be used, reducing the incidence and severity of side effects.</p><p>&nbsp;</p><p><u>Pharmacodynamics effects</u></p><p>&#39;Sinemet&#39; is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. It is frequently helpful in the management of tremor, dysphagia, sialorrhoea, and postural instability associated with Parkinson&#39;s disease and syndrome.</p><p>When response to levodopa alone is irregular, and signs and symptoms of Parkinson&#39;s disease are not controlled evenly throughout the day, substitution of &#39;Sinemet&#39; usually reduces fluctuations in response. By reducing some of the adverse reactions produced by levodopa alone, &#39;Sinemet&#39; permits more patients to obtain adequate relief from the symptoms of Parkinson&#39;s disease.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Following oral dosing levodopa, in the absence of decarboxylase inhibitor, is rapidly but variably absorbed from the gastro-intestinal tract. It has a plasma half-life of about 1 hour and is mainly converted by decarboxylation to dopamine, a proportion of which is converted to noradrenaline. Up to 30 % is converted to 3-O-methyldopa which has a half-life of 9 to 22 hours. About 80 % of levodopa is excreted in the urine within 24 hours mainly as homovanillic acid and dihydroxyphenylactic acid. Less than 1% is excreted unchanged.</p><p>&nbsp;</p><p>Once in the circulation it competes with other neutral amino acids for transport across the blood brain barrier. Once it has entered the striatal neurones it is decarboxylated to dopamine, stored and released from presynaptic neurones. Because levodopa is so rapidly decarboxylated in the gastro-intestinal tract and the liver, very little unchanged drug is available for transport into the brain. The peripheral decarboxylation reduces the therapeutic effectiveness of levodopa but is responsible for many of its side effects. For this reason, levodopa is usually administered together with a peripheral decarboxylase inhibitor such as carbidopa, so that lower doses may be given to achieve the same therapeutic effect.</p><p>&nbsp;</p><p>Carbidopa in the absence of levodopa, is rapidly but incompletely absorbed from the gastrointestinal tract following oral dosing. Following an oral dose approximately 50% is recorded in the urine, with about 3% of this as unchanged drug. It does not cross the blood brain barrier but crosses the placenta and is excreted in breast milk. Turnover of the drug is rapid and virtually all unchanged drug appears in the urine within 7 hours.</p><p>&nbsp;</p><p>Carbidopa inhibits the peripheral decarboxylation of levodopa to dopamine but as it does not cross the blood brain barrier, effective brain levels of dopamine get produced with lower levels of levodopa therapy reducing the peripheral side effects, noticeably nausea and vomiting and cardiac arrhythmias.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sinemet<sup>&reg;</sup> is well established in medical use. Preclinical data is broadly consistent with clinical experience. (For reproductive toxicity, see section 4.6 &#39;Pregnancy and lactation&#39;)</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Inactive ingredients are: Pregelatinized starch, corn starch, microcrystalline cellulose</p><p>and magnesium stearate.</p><p>Sinemet<sup>&reg;</sup> 25/250 mg tablets also contain FD&amp;C Blue #2 (Indigo Carmine). Sinemet<sup>&reg;</sup> 25/100 mg tablets also contain D&amp;C Yellow #10 Aluminum Lake.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
Do not use Sinemet® after the expiry date stated on the blister and carton. The expiry date refers to the last day of that month.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>Store in the original package.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sinemet<sup>&reg;</sup> 25/250 mg is available in blister packs of 20 tablets.<br />Sinemet<sup>&reg;</sup> 25/100 mg is available in blister packs of 100 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Algorithm SAL, Zouk Mosbeh, Lebanon
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2023
 

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>